230 related articles for article (PubMed ID: 31127436)
1. Opioids in cancer-related pain: current situation and outlook.
George B; Minello C; Allano G; Maindet C; Burnod A; Lemaire A
Support Care Cancer; 2019 Aug; 27(8):3105-3118. PubMed ID: 31127436
[TBL] [Abstract][Full Text] [Related]
2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing the use of opioids for breakthrough cancer pain: A secondary analysis of the IOPS-MS study.
Mercadante S; Adile C; Masedu F; Marchetti P; Costanzi A; Aielli F
Eur J Pain; 2019 Apr; 23(4):719-726. PubMed ID: 30421474
[TBL] [Abstract][Full Text] [Related]
4. Breakthrough cancer pain tailored treatment: which factors influence the medication choice? An observational, prospective and cross-sectional study in patients with terminal cancer.
Magnani C; Giannarelli D; Calvieri A; Dardeli A; Eusepi G; Restuccia MR; Mastroianni C; Casale G
Postgrad Med J; 2018 Oct; 94(1116):566-570. PubMed ID: 30317182
[TBL] [Abstract][Full Text] [Related]
5. Opening up disruptive ways of management in cancer pain: the concept of multimorphic pain.
Lemaire A; George B; Maindet C; Burnod A; Allano G; Minello C
Support Care Cancer; 2019 Aug; 27(8):3159-3170. PubMed ID: 31093768
[TBL] [Abstract][Full Text] [Related]
6. Relationships between patient-related attitudinal barriers, analgesic adherence and pain relief in Chinese cancer inpatients.
Ma X; Lu Y; Yang H; Yu W; Hou X; Guo R; Wang Y; Zhang Y
Support Care Cancer; 2020 Jul; 28(7):3145-3151. PubMed ID: 31701270
[TBL] [Abstract][Full Text] [Related]
7. Breakthrough cancer pain and rational drug use.
Olarte JM
Support Care Cancer; 2017 Apr; 25(Suppl 1):11-17. PubMed ID: 28213817
[TBL] [Abstract][Full Text] [Related]
8. Breakthrough Cancer Pain: A Systematic Review of Pharmacologic Management
.
Brant JM; Rodgers BB; Gallagher E; Sundaramurthi T
Clin J Oncol Nurs; 2017 Jun; 21(3 Suppl):71-80. PubMed ID: 28524907
[TBL] [Abstract][Full Text] [Related]
9. Non pharmacological interventions and non-fentanyl pharmacological treatments for breakthrough cancer pain: A systematic and critical review.
Mercadante S
Crit Rev Oncol Hematol; 2018 Feb; 122():60-63. PubMed ID: 29458790
[TBL] [Abstract][Full Text] [Related]
10. Is pain part of a systemic syndrome in head and neck cancer?
Bossi P; Ghiani M; Argenone A; Depenni R
Support Care Cancer; 2020 Feb; 28(2):451-459. PubMed ID: 31713692
[TBL] [Abstract][Full Text] [Related]
11. An overview of the current drug treatment strategies for moderate to severe, chronic malignant tumor-related pain.
Mercadante S
Expert Opin Pharmacother; 2024 Feb; 25(2):171-179. PubMed ID: 37016731
[TBL] [Abstract][Full Text] [Related]
12. A Case-Based Approach to Integrating Opioid Pharmacokinetic and Pharmacodynamic Concepts in Cancer Pain Management.
Lam LH; Pirrello RD; Ma JD
J Clin Pharmacol; 2016 Jul; 56(7):785-93. PubMed ID: 26626053
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled study of fentanyl buccal tablets for breakthrough pain: efficacy and safety in Japanese cancer patients.
Kosugi T; Hamada S; Takigawa C; Shinozaki K; Kunikane H; Goto F; Tanda S; Shima Y; Yomiya K; Matoba M; Adachi I; Yoshimoto T; Eguchi K
J Pain Symptom Manage; 2014 Jun; 47(6):990-1000. PubMed ID: 24099893
[TBL] [Abstract][Full Text] [Related]
14. Breakthrough cancer pain treatment in Spain: physicians' perception of current opioids utilization and prescription.
Villegas Estévez F; López Alarcón MD; Alonso Babarro A; Olay Gayoso L; de Castro J; Lería-Gelabert M; Melogno-Klinkas M
Curr Med Res Opin; 2020 Aug; 36(8):1383-1391. PubMed ID: 32453602
[No Abstract] [Full Text] [Related]
15. Opioid addiction and misuse in adult and adolescent patients with cancer.
Pinkerton R; Hardy JR
Intern Med J; 2017 Jun; 47(6):632-636. PubMed ID: 28580748
[TBL] [Abstract][Full Text] [Related]
16. Selection of opioids for cancer-related pain using a biomarker: a randomized, multi-institutional, open-label trial (RELIEF study).
Matsuoka H; Tsurutani J; Chiba Y; Fujita Y; Terashima M; Yoshida T; Sakai K; Otake Y; Koyama A; Nishio K; Nakagawa K
BMC Cancer; 2017 Oct; 17(1):674. PubMed ID: 28985716
[TBL] [Abstract][Full Text] [Related]
17. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
[TBL] [Abstract][Full Text] [Related]
18. Breakthrough Cancer Pain: Ten Commandments.
Mercadante S; Cuomo A
Value Health; 2016; 19(5):531-6. PubMed ID: 27565269
[TBL] [Abstract][Full Text] [Related]
19. The use of rapid onset fentanyl in children and young people for breakthrough cancer pain.
Coombes L; Burke K; Anderson AK
Scand J Pain; 2017 Oct; 17():256-259. PubMed ID: 29229211
[TBL] [Abstract][Full Text] [Related]
20. Treating breakthrough pain in oncology.
Mercadante S
Expert Rev Anticancer Ther; 2018 May; 18(5):445-449. PubMed ID: 29478355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
